GGrantIndex
Sort

17,288 grants matching multiple sclerosis

The impact of hedgehog signaling during neuroinflammation

$229,360
Jorge Ivan Alvarez · University Of Pennsylvania · K01 · FY2017 · NS

The impact of hedgehog signaling during neuroinflammation

$229,360
Jorge Ivan Alvarez · University Of Pennsylvania · K01 · FY2018 · NS

The impact of hedgehog signaling during neuroinflammation

$229,360
Jorge Ivan Alvarez · University Of Pennsylvania · K01 · FY2016 · NS

Proximal Determinants of Nephritogenic Autoimmunity

$229,343
Mary H Foster · Duke University · R01 · FY2011 · DK

Identification of TSC cellular phenotypes using patient-derived iPSCs

$229,322
Gabriella D'arcangelo · Rutgers, The State Univ Of N.J. · R21 · FY2014 · NS

Immune mechanisms of anti CD40L

$229,321
Brigham And Women'S Hospital · U19 · FY2000 · AI

Anti CD40L in treatment of multiple sclerosis

$229,321
Brigham And Women'S Hospital · U19 · FY2000 · AI

Fumarates for Alcoholic Liver Disease

$229,306
Xiaosong Joy Jiang · University Of California At Davis · R21 · FY2023 · AA

Unobtrusive Monitoring of Affective Symptoms and Cognition using Keyboard Dynamics

$229,293
Olusola Ajilore · University Of Illinois At Chicago · R01 · FY2021 · MH

Project 4: Willis

$229,169
Colin Willis · University Of New England · P20 · FY2012 · GM

Visual outcome measures in children with optic pathway gliomas

$229,113
Robert Andrew Avery · Children'S Research Institute · K23 · FY2014 · EY

UManage Projects Core

$229,106
Annette B Wysocki · University Of Massachusetts Amherst · P20 · FY2017 · NR

Focused ultrasound therapy for remitting the symptoms of MS in a rat model

$229,061
Michael L. Oelze · University Of Illinois At Urbana-Champaign · R21 · FY2017 · NS

Type I Interferon signaling in Bordetella pertussis pathogenesis

$229,025
Nicholas H. Carbonetti · University Of Maryland Baltimore · R21 · FY2018 · AI

Triggering Receptors and CNS Inflammation

$229,015
Scripps Research Institute · R01 · FY2004 · NS

Endocannabinoids, Cannabis, and Neurocognitive Deficits in HIV

$229,012
Brook Henry · University Of California, San Diego · R21 · FY2015 · DA

BDNF-engineered stem cell mediated neuroprotection in EAE

$228,960
Suhayl S. Dhib-Jalbut · Univ Of Med/Dent Nj-R W Johnson Med Sch · R21 · FY2009 · NS

Portable, robotic footwear for real-time control of foot-ground stiffness

$228,959
Meghan E Huber · University Of Massachusetts Amherst · R21 · FY2023 · EB

INTERFERON GAMMA EFFECTS ON OLIGODENDROCYTES

$228,950
University Of Chicago · R01 · FY2002 · NS

Uncovering the hidden universe of metabolite-specific T lymphocytes,using human multiorgan microphysiological systems.

$228,905
Martin Trapecar · Johns Hopkins University · R35 · FY2023 · GM

Novel Therapy for Multiple Sclerosis (SBIR-Phase II)

$228,847
Feng-Qiao Li · Cognosci, Inc. · R44 · FY2007 · NS

Glutamate transporters as regulators of CNS myelination

$228,750
Babette Fuss · Virginia Commonwealth University · R21 · FY2016 · NS

Lipidomic profile of endocannabinoids from neuronal cells

$228,750
Eric L Barker · Purdue University · R21 · FY2009 · DA

p38 MAPK as a female-specific druggable target in CNS autoimmune disease

$228,750
Cory Teuscher · University Of Vermont & St Agric College · R21 · FY2011 · NS

Discovery and evaluation of novel therapy for Niemann-Pick type C targeting NPC1

$228,750
Sarah Spiegel · Virginia Commonwealth University · R21 · FY2014 · NS